News

Data2Life featured at recent event by Takeda Pharmaceuticals

Posted September 6, 2016

Data2Life was among several companies to attend a recent two-day scouting event for digital healthcare companies hosted by Japan-based drug company Takeda Pharmaceuticals. Following the event, Stephanie Bova, Head of Europe, Middle East and Africa for Takeda Pharmaceuticals noted:

What I liked about [Data2Life] is their capability to simultaneously examine data from social networks and patient communities, as well as more structured information from medical records, in order to provide advance warning regarding drug side effects, based on the intersection between symptoms appearing in the records and conversations between patients. They compete with well-established companies in this field in the US, and are doing it better.